marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Vanda Pharmaceuticals Cash Flow 2011-2024 | VNDA
Annual Cash Flow Vanda Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
12.8 M | 32 M | 64.2 M | 51.8 M | 45.9 M | 30 M | -1.98 M | - | - | - | -39.6 M | -44.9 M | -28.4 M |
Depreciation & Amortization |
920 K | 1.22 M | 1.36 M | 1.39 M | 1.39 M | 1.43 M | 1.23 M | 935 K | 582 K | 530 K | 432 K | 633 K | 469 K |
Accounts Payables |
- | - | - | - | - | - | - | - | - | 835 K | 661 K | 287 K | 996 K |
Accounts Receivables |
34.2 M | 33.5 M | 32.5 M | 30 M | 26.4 M | 28.8 M | 17.6 M | 20.3 M | 16.3 M | 3.65 M | 2.03 M | 1.17 M | 1.62 M |
Total Inventories |
1.36 M | 1.19 M | 1.02 M | 1.28 M | 1.14 M | 994 K | 840 K | 779 K | 1.29 M | 5.17 M | - | 57 K | - |
All numbers in USD currency
Quarterly Cash Flow Vanda Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | - | - | - | 31.8 M | - | 22.6 M | - | 4.05 M | - | 37.6 M | - | 9.19 M | - | 32.5 M | 23.1 M | -907 K | - | 36.2 M | 30.2 M | 9.64 M | - | 14.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -23.9 M | - | - | - | -9.12 M | - | -31.1 M | -20.9 M | -8.69 M | - | -16.1 M | -8.88 M | -3.26 M |
Depreciation & Amortization |
1.75 M | 1.75 M | - | 380 K | 378 K | 291 K | - | 379 K | 379 K | 323 K | - | 1.03 M | 369 K | 345 K | - | 1.04 M | 694 K | 351 K | - | 1.02 M | 672 K | 332 K | - | 1.06 M | 706 K | 349 K | - | 895 K | 553 K | 250 K | - | 654 K | 435 K | 219 K | - | 420 K | 263 K | 140 K | - | 396 K | 264 K | 125 K | - | 321 K | 212 K | 107 K | - | 528 K | 424 K | 331 K | - | 284 K | 138 K | 77 K |
Accounts Payables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.63 M | 1.49 M | 835 K | 547 K | 248 K | 835 K | 661 K | 661 K | 661 K | 661 K | 287 K | 287 K | 287 K | 287 K | 996 K | 996 K | 996 K | 996 K |
Accounts Receivables |
42.8 M | 41.9 M | 34.2 M | 29.3 M | 33.6 M | 24.5 M | 33.5 M | 29.4 M | - | 30.5 M | 32.5 M | 41.5 M | 37.1 M | 31.5 M | 30 M | 30 M | 30 M | 30 M | 26.4 M | 26.4 M | 26.4 M | 26.4 M | 28.8 M | 28.8 M | 28.8 M | 28.8 M | 17.6 M | 17.6 M | 17.6 M | 17.6 M | 20.3 M | 20.3 M | 20.3 M | 20.3 M | 16.3 M | 16.3 M | 16.3 M | 16.3 M | 3.65 M | 3.65 M | 3.65 M | 3.65 M | 2.03 M | 2.03 M | 2.03 M | 2.03 M | 1.17 M | 1.17 M | 1.17 M | 1.17 M | 1.62 M | 1.62 M | 1.62 M | 1.62 M |
Total Inventories |
1.61 M | 1.47 M | 1.36 M | 1.01 M | 1.08 M | 1.1 M | 1.19 M | 1.59 M | - | 1.29 M | 1.02 M | 902 K | 1.06 M | 1.36 M | 1.28 M | 1.28 M | 1.28 M | 1.28 M | 1.14 M | 1.14 M | 1.14 M | 1.14 M | 994 K | 994 K | 994 K | 994 K | 840 K | 840 K | 840 K | 840 K | 779 K | 779 K | 779 K | 779 K | 1.29 M | 1.29 M | 1.29 M | 1.29 M | 5.17 M | 5.17 M | 5.17 M | 5.17 M | - | - | 28 K | 21 K | 57 K | 161 K | 57 K | 57 K | - | - | - | - |
All numbers in USD currency